Companies in the fields that performed well in the first quarter, namely the pharmaceutical and oil and gas ones, did not let investors down in the second quarter, either, posting both turnover and profit increases.
The cumulated turnover of oil and gas companies on the Stock Exchange that have recently reported their figures in the first six months went up by 12%, to 12.4bn RON (2.9bn euros), with profits also increasing, by 14%.
Analysts account for growth in this field by the rising oil prices internationally and say it has nothing to do with what is happening in the economy.
Pharmaceutical companies further saw their profits soar overall, with incomes advancing by 68%, after turnovers went up by 21%, the strongest increase among analysed fields.
Growth in these fields was above the average one posted by Bucharest Stock Exchange issuers.
The cumulated sales of 71 listed companies in the first half went up by 13% from a year ago, to 9.4bn RON (2.3bn euros), according to ZF data.
"The data were good, but the economy is still under the pressure of some uncertainty. Domestic consumption is still the main problem and it's not sure whether it will be balanced by exports. (...)," says Mihai Iulian C`runtu, head of the Capital Market Research Department of BCR.
Companies in the fields that performed well in the first quarter, namely the pharmaceutical and oil and gas ones, did not let investors down in the second quarter, either, posting both turnover and profit increases.
The cumulated turnover of oil and gas companies on the Stock Exchange that have recently reported their figures in the first six months went up by 12%, to 12.4bn RON (2.9bn euros), with profits also increasing, by 14%.
Analysts account for growth in this field by the rising oil prices internationally and say it has nothing to do with what